GlassScriptPhysician profile
Brent A Clower
NPI 1447488564
$465.83
in general payments reported to CMS, 2019-2025
12 companies · $34.98 in 2025
The $34.98 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2022: $57.34 · 2023: $42.67 · 2024: $139 · 2025: $34.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $118.14 | 2019 | |
| Abbvie INC. | $58.05 | 2022-2024 | Qulipta |
| Melinta Therapeutics, LLC | $50.54 | 2019 | |
| Collegium Pharmaceutical, INC. | $48.76 | 2024 | Xtampza |
| Spr Therapeutics, INC | $43.41 | 2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $32.46 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $27.90 | 2023 | Ajovy |
| Neurocrine Biosciences, INC. | $22.85 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.43 | 2025 | Caplyta |
| Aroa Biosurgery Incorporated | $14.63 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.11 | 2022 | |
| Axsome Therapeutics, INC. | $13.55 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Clower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.